LGR6
Basic information
Region (hg38): 1:202193799-202319781
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LGR6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 57 | 60 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 0 | 57 | 4 | 3 |
Variants in LGR6
This is a list of pathogenic ClinVar variants found in the LGR6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-202194068-C-A | not specified | Uncertain significance (Oct 06, 2021) | ||
1-202194108-A-C | not specified | Uncertain significance (Jul 19, 2022) | ||
1-202227953-A-G | not specified | Uncertain significance (Nov 16, 2021) | ||
1-202235956-G-A | not specified | Uncertain significance (Jul 16, 2021) | ||
1-202235963-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
1-202235978-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
1-202276308-G-A | not specified | Uncertain significance (May 03, 2023) | ||
1-202276316-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
1-202276370-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
1-202276392-A-G | not specified | Uncertain significance (Nov 10, 2022) | ||
1-202276467-G-A | not specified | Uncertain significance (Mar 03, 2022) | ||
1-202276487-T-G | not specified | Uncertain significance (Mar 21, 2022) | ||
1-202276491-C-T | not specified | Uncertain significance (Apr 03, 2023) | ||
1-202297508-A-T | not specified | Likely benign (Nov 07, 2023) | ||
1-202297545-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
1-202303295-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
1-202304570-G-A | Benign/Likely benign (Dec 01, 2022) | |||
1-202306884-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
1-202306917-C-A | not specified | Uncertain significance (Feb 10, 2022) | ||
1-202307364-C-G | not specified | Uncertain significance (Dec 07, 2023) | ||
1-202309059-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
1-202309101-G-T | not specified | Uncertain significance (Mar 02, 2023) | ||
1-202309154-A-G | not specified | Uncertain significance (Oct 24, 2023) | ||
1-202310191-C-G | Benign (Jun 26, 2018) | |||
1-202310295-T-C | not specified | Uncertain significance (Jun 02, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LGR6 | protein_coding | protein_coding | ENST00000367278 | 18 | 125881 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000294 | 1.00 | 125708 | 0 | 40 | 125748 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.07 | 482 | 553 | 0.872 | 0.0000320 | 6143 |
Missense in Polyphen | 170 | 223.76 | 0.75975 | 2606 | ||
Synonymous | 0.496 | 245 | 255 | 0.960 | 0.0000155 | 2105 |
Loss of Function | 3.31 | 16 | 38.0 | 0.421 | 0.00000177 | 431 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000149 | 0.000148 |
Ashkenazi Jewish | 0.000215 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000152 | 0.000149 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000427 | 0.000425 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for R-spondins that potentiates the canonical Wnt signaling pathway and acts as a marker of multipotent stem cells in the epidermis. Upon binding to R-spondins (RSPO1, RSPO2, RSPO3 or RSPO4), associates with phosphorylated LRP6 and frizzled receptors that are activated by extracellular Wnt receptors, triggering the canonical Wnt signaling pathway to increase expression of target genes. In contrast to classical G-protein coupled receptors, does not activate heterotrimeric G-proteins to transduce the signal. May act as a tumor suppressor. {ECO:0000269|PubMed:21727895, ECO:0000269|PubMed:22615920}.;
- Pathway
- GPCRs, Other;Signaling by WNT;Signal Transduction;Regulation of FZD by ubiquitination;TCF dependent signaling in response to WNT
(Consensus)
Intolerance Scores
- loftool
- 0.232
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 45.69
Haploinsufficiency Scores
- pHI
- 0.132
- hipred
- Y
- hipred_score
- 0.663
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0700
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lgr6
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;Wnt signaling pathway;positive regulation of Wnt signaling pathway;positive regulation of cell migration;positive regulation of canonical Wnt signaling pathway;bone regeneration
- Cellular component
- plasma membrane;integral component of plasma membrane;vesicle;trans-Golgi network membrane
- Molecular function
- transmembrane signaling receptor activity;G protein-coupled receptor activity;protein binding;protein-hormone receptor activity